It's been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Viking Therapeutics' leading candidate, VK2735, is a potential GLP-1 weight loss medicine. It reported ...
"After years of feeling exhausted, embarrassed and out of control I truly thought I was destined to be this way forever. It is true to say I had disappeared inside myself, I was in a toxic ...